CSL broadens anti-rejection portfolio

Biotechnology group CSL has bought Vitaeris Inc, a clinical-stage biotechnology company commercialising a treatment for rejection in solid organ kidney transplant patients. The Vancouver, Canada based company has been in partnership with CSL since 2017 developing clazakizumab, an anti-interleukin-6 (IL-6) monoclonal antibody (MAB), for the potential treatment of chronic active antibody-mediated rejection (AMR), the leading…

K-Tig to work with Bisalloy and Axiom Precision in defence

Welding technology developer K-TIG is to work with Bisalloy Steels and Axiom Precision Manufacturing to develop specialist welding capabilities for the defence sector. The three companies have signed a memorandum of understanding to jointly develop a sovereign capability in the efficient and effective welding of specialist steels. Their target is to maximise Australian participation in…

Xtek to ramp up ballistic armour production

Ballistic armour manufacturer Xtek has secured loan funding to allow the expansion of its ballistic helmet manufacturing facility in Adelaide. The company secured a $2.5 million loan from the Commonwealth Bank which will be used to install commercial scale preform presses needed before the company’s proprietary XTclave composite materials curing and consolidation process. The process…